Dual-sugar tests of small intestinal permeability are poor predictors of bacterial infections and mortality in cirrhosis: A prospective study

World Journal of Gastroenterology

Volumn 22, Issue 11, 2016, Pages 3275-3284

  Vogt, Anika ^a   Reuken, Philipp A ^a   Stengel, Sven ^a   Stallmach, Andreas ^a   Bruns, Tony ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Bacterial translocation; Intestinal permeability; Lactulose mannitol ratio; Liver cirrhosis; Spontaneous bacterial peritonitis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; FATTY ACID BINDING PROTEIN 2; INTERLEUKIN 6; LACTULOSE; LIPOPOLYSACCHARIDE BINDING PROTEIN; MANNITOL; PROTON PUMP INHIBITOR; TERLIPRESSIN; AUTACOID;

ADULT; ARTICLE; ASCITES; BACTERIAL INFECTION; BACTERIAL PERITONITIS; CAMPYLOBACTER ENTERITIS; CHILD PUGH SCORE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; ENTEROCOLITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTESTINE CELL; INTESTINE MUCOSA PERMEABILITY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MYCOSIS; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PNEUMONIA; PROSPECTIVE STUDY; SMALL INTESTINE; THROMBOCYTE COUNT; AGED; BACTERIAL INFECTIONS; BACTERIAL TRANSLOCATION; BLOOD; CASE CONTROL STUDY; INTESTINE FLORA; KAPLAN MEIER METHOD; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PERITONITIS; PERMEABILITY; PREDICTIVE VALUE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; BACTERIAL TRANSLOCATION; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GASTROINTESTINAL MICROBIOME; HOSPITALIZATION; HUMANS; INFLAMMATION MEDIATORS; INTESTINE, SMALL; KAPLAN-MEIER ESTIMATE; LACTULOSE; LINEAR MODELS; LIVER CIRRHOSIS; MALE; MANNITOL; MIDDLE AGED; PERITONITIS; PERMEABILITY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84960864951     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i11.3275     Document Type: Article

References (33)

1. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993; 18: 353-358. [PMID: 8228129. DOI: 10.1016/S0168-8278(05)80280-6
2. Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, Boccia S, Colloredo-Mels G, Corigliano P, Fornaciari G, Marenco G, Pistarà R, Salvagnini M, Sangiovanni A. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 2001; 33: 41-48. [PMID: 11303974
3. Fernández J, Navasa M, Gömez J, Colmenero J, Vila J, Arroyo V, Rodés J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140-148. [PMID: 11786970. DOI: 10.1053/jhep.2002.30082
4. Fernández J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, Pavesi M, Sola E, Moreira L, Silva A, Seva-Pereira T, Corradi F, Mensa J, Ginès P, Arroyo V. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology 2012; 55: 1551-1561. [PMID: 22183941. DOI: 10.1002/hep.25532
5. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, Wendon J, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M, Arroyo V. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144: 1426-1437, 1437.e1-e9. [PMID: 23474284. DOI: 10.1053/j.gastro.2013.02.042
6. Arvaniti V, D'Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, Burroughs AK. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010; 1246-1256, 1256.e1-e5. [PMID: 20558165. DOI: 10.1053/j.gastro.2010.06.019
7. Runyon BA, McHutchison JG, Antillon MR, Akriviadis EA, Montano AA. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology 1991; 100: 1737-1742. [PMID: 2019378
8. Scarpellini E, Valenza V, Gabrielli M, Lauritano EC, Perotti G, Merra G, Dal Lago A, Ojetti V, Ainora ME, Santoro M, Ghirlanda G, Gasbarrini A. Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? Am J Gastroenterol 2010; 105: 323-327. [PMID: 19844200. DOI: 10.1038/ajg.2009.558
9. Teltschik Z, Wiest R, Beisner J, Nuding S, Hofmann C, Schoelmerich J, Bevins CL, Stange EF, Wehkamp J. Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense. Hepatology 2012; 55: 1154-1163. [PMID: 22095436. DOI: 10.1002/hep.24789
10. Bruns T, Zimmermann HW, Stallmach A. Risk factors and outcome of bacterial infections in cirrhosis. World J Gastroenterol 2014; 20: 2542-2554. [PMID: 24627590. DOI: 10.3748/wjg.v20.i10.2542
11. Liboredo JC, Vilela EG, Ferrari Mde L, Lima AS, Correia MI. Nutrition status and intestinal permeability in patients eligible for liver transplantation. JPEN J Parenter Enteral Nutr 2015; 39: 163-170. [PMID: 24255087. DOI: 10.1177/0148607113513465
12. Pascual S, Such J, Esteban A, Zapater P, Casellas JA, Aparicio JR, Girona E, Gutiérrez A, Carnices F, Palazön JM, Sola-Vera J, Pérez-Mateo M. Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterology 2003; 50: 1482-1486. [PMID: 14571769
13. Norman K, Pirlich M, Schulzke JD, Smoliner C, Lochs H, Valentini L, Bühner S. Increased intestinal permeability in malnourished patients with liver cirrhosis. Eur J Clin Nutr 2012; 66: 1116-1119. [PMID: 22872031. DOI: 10.1038/ejcn.2012.104
14. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005; 41: 422-433. [PMID: 15723320. DOI: 10.1002/hep.20632
15. Reiberger T, Ferlitsch A, Payer BA, Mandorfer M, Heinisch BB, Hayden H, Lammert F, Trauner M, Peck-Radosavljevic M, Vogelsang H. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. J Hepatol 2013; 58: 911-921. [PMID: 23262249. DOI: 10.1016/j.jhep.2012.12.011
16. Katouli M, Nettebladt CG, Muratov V, Ljungqvist O, Bark T, Svenberg T, Möllby R. Selective translocation of coliform bacteria adhering to caecal epithelium of rats during catabolic stress. J Med Microbiol 1997; 46: 571-578. [PMID: 9236741. DOI: 10.1099/00222615-46-7-571
17. Clark E, Hoare C, Tanianis-Hughes J, Carlson GL, Warhurst G. Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology 2005; 128: 1258-1267. [PMID: 15887109. DOI: 10.1053/j.gastro.2005.01.046
18. Macutkiewicz C, Carlson G, Clark E, Dobrindt U, Roberts I, Warhurst G. Characterisation of Escherichia coli strains involved in transcytosis across gut epithelial cells exposed to metabolic and inflammatory stress. Microbes Infect 2008; 10: 424-431. [PMID: 18403240. DOI: 10.1016/j.micinf.2008.01.001
19. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003; 171: 6164-6172. [PMID: 14634132. DOI: 10.4049/jimmunol.171.11.6164
20. Campillo B, Pernet P, Bories PN, Richardet JP, Devanlay M, Aussel C. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol 1999; 11: 755-759. [PMID: 10445796. DOI: 10.1097/00042737-199907000-00013
21. Benjamin J, Singla V, Arora I, Sood S, Joshi YK. Intestinal permeability and complications in liver cirrhosis: A prospective cohort study. Hepatol Res 2013; 43: 200-207. [PMID: 22726344. DOI: 10.1111/j.1872-034X.2012.01054.x
22. Cariello R, Federico A, Sapone A, Tuccillo C, Scialdone VR, Tiso A, Miranda A, Portincasa P, Carbonara V, Palasciano G, Martorelli L, Esposito P, Cartenì M, Del Vecchio Blanco C, Loguercio C. Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage. Dig Liver Dis 2010; 42: 200-204. [PMID: 19502117. DOI: 10.1016/j.dld.2009.05.001
23. Goto K, Chew F, Torún B, Peerson JM, Brown KH. Epidemiology of altered intestinal permeability to lactulose and mannitol in Guatemalan infants. J Pediatr Gastroenterol Nutr 1999; 28: 282-290. [PMID: 10067729
24. Bruns T, Peter J, Hagel S, Herrmann A, Stallmach A. The augmented neutrophil respiratory burst in response to Escherichia coli is reduced in liver cirrhosis during infection. Clin Exp Immunol 2011; 164: 346-356. [PMID: 21413941. DOI: 10.1111/j.1365-2249.2011.04373.x
25. Wang L, Llorente C, Hartmann P, Yang AM, Chen P, Schnabl B. Methods to determine intestinal permeability and bacterial translocation during liver disease. J Immunol Methods 2015; 421: 44-53. [PMID: 25595554. DOI: 10.1016/j.jim.2014.12.015
26. Albillos A, de la Hera A, González M, Moya JL, Calleja JL, Monserrat J, Ruiz-del-Arbol L, Alvarez-Mon M. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003; 37: 208-217. [PMID: 12500206. DOI: 10.1053/jhep.2003.50038
27. Tang NY, Chen WQ. [Significance of lipopolysaccharide binding protein in serum and ascites of patients with hepatic cirrhosis complicated with spontaneous bacterial peritonitis]. Zhonghua Ganzangbing Zazhi 2012; 20: 492-496. [PMID: 23044232
28. Glatz JF, van der Vusse GJ. Cellular fatty acid-binding proteins: their function and physiological significance. Prog Lipid Res 1996; 35: 243-282. [PMID: 9082452. DOI: 10.1016/S0163-7827(96)00006-9
29. Sandler NG, Koh C, Roque A, Eccleston JL, Siegel RB, Demino M, Kleiner DE, Deeks SG, Liang TJ, Heller T, Douek DC. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 2011; 141: 1220-1230, 1230.e1-e3. [PMID: 21726511. DOI: 10.1053/j.gastro.2011.06.063
30. Villa E, Cammà C, Marietta M, Luongo M, Critelli R, Colopi S, Tata C, Zecchini R, Gitto S, Petta S, Lei B, Bernabucci V, Vukotic R, De Maria N, Schepis F, Karampatou A, Caporali C, Simoni L, Del Buono M, Zambotto B, Turola E, Fornaciari G, Schianchi S, Ferrari A, Valla D. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology 2012; 143: 1253-1260.e1-e4. [PMID: 22819864. DOI: 10.1053/j.gastro.2012.07.018
31. Güzel M, Sözüer EM, Salt Ö, Ikizceli I, Akdur O, Yazici C. Value of the serum I-FABP level for diagnosing acute mesenteric ischemia. Surg Today 2014; 44: 2072-2076. [PMID: 24337529. DOI: 10.1007/s00595-013-0810-3
32. Matsumoto S, Sekine K, Funaoka H, Yamazaki M, Shimizu M, Hayashida K, Kitano M. Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia. Br J Surg 2014; 101: 232-238. [PMID: 24402763. DOI: 10.1002/bjs.9331
33. Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol 2014; 60: 197-209. [PMID: 23993913. DOI: 10.1016/j.jhep.2013.07.044